Paediatric Haematology and Oncology

Uzm. Dr. Seda Öztürkmen

Doctor and researcher Medical Park Antalya İstanbul
Graft vs Host DiseaseLymphoproliferative DisordersThalassemiabeta-ThalassemiaVitamin D DeficiencyLeukemia, Myeloid, AcuteAsthma
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • Graft vs Host Disease 9 publications
    Source: OpenAlex / PubMed MeSHView publications
  • Lymphoproliferative Disorders 2 publications
  • Thalassemia 2 publications
  • beta-Thalassemia 2 publications
  • Vitamin D Deficiency 2 publications
  • Leukemia, Myeloid, Acute 2 publications
  • Asthma 2 publications

Person ↔ Disease

Which topics does this doctor work on?

From source

Medical areas of interest stated by the doctor on the institution profile. Source: medicalpark.com.tr.

  • Kemik iliği nakli
  • Talasemi
  • Talasemi Lösemi

CV

Education and experience

From source

Experience

  • ExperienceMedical Park Antalyamedicalpark.com.tr

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyPaediatric Haematology and Oncologymedicalpark.com.trFrom source
  • InstitutionMedical Park Antalyamedicalpark.com.trFrom source
  • Area of workGraft vs Host DiseaseExtracted from 9 publications · Model version —From source
  • Publications38 publicationsOpenAlexFrom source
  • ORCID0000-0002-6713-0147ORCIDFrom source
  • Last synchronised4 November 2026 20:54https://www.medicalpark.com.tr/hekimler/seda-ozturkmenmedicalpark.com.tr

Scientific work

Publications on Graft vs Host Disease

38 publications

  1. The Pretransplant EASIX Score Predicts Transplant‐Related Mortality in Children Undergoing Hematopoietic Stem Cell Transplantation for Non‐Malignant Disorders

    Clinical Transplantation, 2026

    DOI 10.1111/ctr.70487 PMID 41729158 Source: OpenAlex

  2. Frequency, Characteristics, Management, and Outcomes of Posttransplant Lymphoproliferative Disorder After Allogeneic Hematopoietic Stem Cell Transplantation in Children: A Multicentre Retrospective Study of the Turkish Pediatric BMT Study Group

    Turkish Journal of Hematology, 2026

    DOI 10.4274/tjh.galenos.2026.55376 PMID 41778738 Open-access full textSource: OpenAlex

  3. Hematopoietic stem cell transplantation in pediatric patients with type VI mucopolysaccharidosis

    Korean Journal of Pediatrics, 2025

    DOI 10.3345/cep.2024.02033 PMID 40083103 2 citations (Europe PMC) Open-access full textSource: OpenAlex

  4. Effect of genetic mutations on outcomes of stem cell transplantation in children with hemophagocytic lymphohistiocytosis

    Bone Marrow Transplantation, 2025

    DOI 10.1038/s41409-025-02592-4 PMID 40263637 3 citations (Europe PMC) Open-access full textSource: OpenAlex

  5. COVID‐19 disease in children and adolescents following allogeneic hematopoietic stem cell transplantation: A report from the Turkish pediatric bone marrow transplantation study group

    Pediatric Transplantation, 2024

    DOI 10.1111/petr.14758 PMID 38659218 Open-access full textSource: OpenAlex

  6. Hematopoietic stem cell transplantation in children with mucopolysaccharidosis IVA: single center experience

    Bone Marrow Transplantation, 2024

    DOI 10.1038/s41409-024-02439-4 PMID 39402187 10 citations (Europe PMC) Open-access full textSource: OpenAlex

  7. Comparison of tacrolimus vs. cyclosporine in pediatric hematopoietic stem cell transplantation for thalassemia

    Pediatric Transplantation, 2024

    DOI 10.1111/petr.14688 PMID 38317344 1 citation (Europe PMC) Open-access full textSource: OpenAlex

  8. Combined Haploidentical Hematopoetic Stem Cell Transplantation and Liver Transplantation in a Pediatric Patient

    International Journal of Hematology-Oncology and Stem Cell Research, 2023

    DOI 10.18502/ijhoscr.v17i4.13921 PMID 38076781 Open-access full textSource: OpenAlex

  9. Long-Term Survival Outcomes of Hematopetic Stem Cell Transplantation in Thalassemia Major Patients

    LLM Dergi, 2023

    DOI 10.5578/llm.20239702 Open-access full textSource: OpenAlex

  10. Thalassemia-free and graft-versus-host-free survival: outcomes of hematopoietic stem cell transplantation for thalassemia major, Turkish experience

    Bone Marrow Transplantation, 2022

    DOI 10.1038/s41409-022-01613-w PMID 35210564 20 citations (Europe PMC) Source: OpenAlex

View all 38 publications